{"_buckets": {"deposit": "4f9d718b-f619-4b23-adff-94bfcf8e5e19"}, "_deposit": {"id": "14342", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "14342"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00014342", "sets": []}, "author_link": ["87680"], "item_1615768549627": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-03-28", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "193", "bibliographicPageStart": "175", "bibliographicVolumeNumber": "41", "bibliographic_titles": [{"bibliographic_title": "国際開発研究フォーラム", "bibliographic_titleLang": "ja"}, {"bibliographic_title": "Forum of International Development Studies", "bibliographic_titleLang": "en"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Th World Health Organization estimates that only approximately one third of the world population have regular access to essential medication. Most of the deprived households are in developing countries. Studies on the pharmaceutical industry are thus particularly relevant for improving the health situation of the developing world and to increase new drug development for diseases that afflict the poor. Furthermore, as a knowledge-intensive sector, the pharmaceutical industry is of strategic importance for decreasing the developing countries\u0027 dependence on foreign technology and to stimulate innovation. This paper is based on fieldwork visits to state-owned pharmaceutical laboratories and semi-structured interviews with key public officials in Brazil and aims to analyze what kind of policy mixture is the most effective in order to ensure access to essential medicines in developing countries and to nurture the growth of the domestic pharmaceutical industry. It shows that centralized public procurement is being used by the Brazilian government to nurture the development of the pharmaceutical industry and improve health care delivery. In addition, it demonstrates that the technology backwardness of the Brazilian pharmaceutical sector and the lack of alignment between the Ministry of Health\u0027s priorities and public laboratories\u0027 production activities are critical constraints for the sustainability of public health programmes in Brazil.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/forids.41.175", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "名古屋大学大学院国際開発研究科", "subitem_publisher_language": "ja"}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_61": {"attribute_name": "ISSN（Online）", "attribute_value_mlt": [{"subitem_source_identifier": "2189-9126", "subitem_source_identifier_type": "EISSN"}]}, "item_9_source_id_7": {"attribute_name": "ISSN（print）", "attribute_value_mlt": [{"subitem_source_identifier": "1341-3732", "subitem_source_identifier_type": "PISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "SORTE, JUNIOR  Waldemiro Francisco", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "87680", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-20"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "10.pdf", "filesize": [{"value": "6.2 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 6200000.0, "url": {"label": "10.pdf", "objectType": "fulltext", "url": "https://nagoya.repo.nii.ac.jp/record/14342/files/10.pdf"}, "version_id": "3865013e-e120-4882-ab97-a3471afa3f64"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Access to Essential Medicines", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Centralized Procurement", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Public Laboratories", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Brazilian Pharmaceutical Industry", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The Role of Governmental Policies in Nurturing the Pharmaceutical Industry in Brazil: The Mix of Centralized Procurement, Public Drug Production and Public-private Partnerships", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The Role of Governmental Policies in Nurturing the Pharmaceutical Industry in Brazil: The Mix of Centralized Procurement, Public Drug Production and Public-private Partnerships", "subitem_title_language": "en"}]}, "item_type_id": "9", "owner": "1", "path": ["1389"], "permalink_uri": "https://doi.org/10.18999/forids.41.175", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2012-04-12"}, "publish_date": "2012-04-12", "publish_status": "0", "recid": "14342", "relation": {}, "relation_version_is_last": true, "title": ["The Role of Governmental Policies in Nurturing the Pharmaceutical Industry in Brazil: The Mix of Centralized Procurement, Public Drug Production and Public-private Partnerships"], "weko_shared_id": -1}